Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct
- 26 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (6), 1062-1064
- https://doi.org/10.1212/01.wnl.0000237343.93389.35
Abstract
We sought to determine whether Swedish patients with multiple sclerosis (MS) with and without oligoclonal bands (OCBs) in the CSF constitute distinct subpopulations, clinically and immunogenetically. Our findings indicate that OCB-negative MS shares the same clinical features as OCB-positive MS regarding female predominance, age at onset, proportion of primary progressive cases, rate of MRI positivity, and disease severity. Our HLA-DRB1 genotyping results suggest, however, that OCB-positive and OCB-negative MS are immunogenetically distinct.Keywords
This publication has 8 references indexed in Scilit:
- Multiple Sclerosis Severity ScoreNeurology, 2005
- HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bandsNeurology, 2003
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- Hla class II association with rheumatoid arthritisHuman Immunology, 2000
- Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosisBrain, 1997
- A study of oligoclonal band negative multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Sardinian multiple sclerosis is associated with HLA‐DR4Neurology, 1988
- Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.Clinical Chemistry, 1984